VCNX
Morgan Stanley’s Vaccinex, Inc. Common Stock VCNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4
| Closed | -$14 | – | 8175 |
|
|
2024
Q3 | $14 | Sell |
4
-1,109
| -100% | -$3.88K | ﹤0.01% | 7846 |
|
|
2024
Q2 | $7.22K | Hold |
1,113
| – | – | ﹤0.01% | 6766 |
|
|
2024
Q1 | $8.25K | Buy |
1,113
+1,073
| +2,683% | +$7.95K | ﹤0.01% | 6765 |
|
|
2023
Q4 | $26 | Buy |
40
+20
| +100% | +$13 | ﹤0.01% | 7746 |
|
|
2023
Q3 | $23 | Sell |
20
-280
| -93% | -$322 | ﹤0.01% | 7533 |
|
|
2023
Q2 | $107 | Hold |
300
| – | – | ﹤0.01% | 7491 |
|
|
2023
Q1 | $120 | Hold |
300
| – | – | ﹤0.01% | 7555 |
|
|
2022
Q4 | $193 | Sell |
300
-64
| -18% | -$41 | ﹤0.01% | 7647 |
|
|
2022
Q3 | $0 | Buy |
364
+64
| +21% | – | ﹤0.01% | 7939 |
|
|
2022
Q2 | $0 | Sell |
300
-860
| -74% | – | ﹤0.01% | 8040 |
|
|
2022
Q1 | $1K | Buy |
1,160
+860
| +287% | +$741 | ﹤0.01% | 7884 |
|
|
2021
Q4 | $0 | Sell |
300
-201
| -40% | – | ﹤0.01% | 8152 |
|
|
2021
Q3 | $1K | Buy |
501
+1
| +0.2% | +$2 | ﹤0.01% | 7818 |
|
|
2021
Q2 | $1K | Hold |
500
| – | – | ﹤0.01% | 7644 |
|
|
2021
Q1 | $1K | Buy |
500
+200
| +67% | +$400 | ﹤0.01% | 7394 |
|
|
2020
Q4 | $1K | Sell |
300
-278
| -48% | -$927 | ﹤0.01% | 6984 |
|
|
2020
Q3 | $1K | Buy |
578
+278
| +93% | +$481 | ﹤0.01% | 6682 |
|
|
2020
Q2 | $1K | Sell |
300
-4
| -1% | -$13 | ﹤0.01% | 6540 |
|
|
2020
Q1 | $1K | Sell |
304
-5
| -2% | -$16 | ﹤0.01% | 6503 |
|
|
2019
Q4 | $1K | Buy |
+309
| New | +$1K | ﹤0.01% | 6601 |
|
|
2019
Q3 | – | Sell |
-31
| Closed | – | – | 6791 |
|
|
2019
Q2 | $0 | Sell |
31
-6
| -16% | – | ﹤0.01% | 6778 |
|
|
2019
Q1 | $0 | Sell |
37
-4
| -10% | – | ﹤0.01% | 6739 |
|
|
2018
Q4 | $0 | Sell |
41
-2,535
| -98% | – | ﹤0.01% | 6766 |
|
|
2018
Q3 | $19K | Buy |
+2,576
| New | +$19K | ﹤0.01% | 6160 |
|